Analyst Ratings For Albemarle

Throughout the last three months, 11 analysts have evaluated Albemarle ALB, offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 4 5 0 0
Last 30D 0 0 1 0 0
1M Ago 0 1 1 0 0
2M Ago 0 2 2 0 0
3M Ago 2 1 1 0 0

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.27, a high estimate of $160.00, and a low estimate of $124.00. Marking an increase of 5.73%, the current average surpasses the previous average price target of $136.45.

price target chart

Interpreting Analyst Ratings: A Closer Look

The standing of Albemarle among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Joshua Spector UBS Lowers Neutral $124.00 $132.00
Arun Viswanathan RBC Capital Maintains Outperform $157.00 $157.00
Ben Isaacson Scotiabank Lowers Sector Perform $135.00 $150.00
Corinne Blanchard Deutsche Bank Raises Hold $140.00 $125.00
Ben Isaacson Scotiabank Lowers Sector Outperform $150.00 $160.00
Arun Viswanathan RBC Capital Raises Outperform $157.00 $138.00
John Roberts Mizuho Raises Neutral $128.00 $112.00
Michael Sison Wells Fargo Raises Overweight $145.00 $135.00
Andres Castanos Mollor Berenberg Raises Buy $160.00 $130.00
Patrick Cunningham Citigroup Raises Neutral $135.00 $125.00
Matthew DeYoe B of A Securities Raises Buy $156.00 $137.00

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Albemarle. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Albemarle compared to the broader market.
  • Price Targets: Delving into movements, analysts provide estimates for the future value of Albemarle's stock. This analysis reveals shifts in analysts' expectations over time.

For valuable insights into Albemarle's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Albemarle analyst ratings.

About Albemarle

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.

Financial Milestones: Albemarle's Journey

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Growth: Albemarle's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -47.26%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.

Net Margin: Albemarle's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.67%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Albemarle's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.1%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.05%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Albemarle's debt-to-equity ratio is below the industry average at 0.38, reflecting a lower dependency on debt financing and a more conservative financial approach.

Analyst Ratings: Simplified

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!